Start Time: 08:30 January 1, 0000 9:27 AM ET

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)

Q1 2023 Earnings Conference Call

May 04, 2023, 08:30 AM ET

Company Participants

Peter Greenleaf - President and CEO

Joe Miller - CFO

Jamie Harrell - Head of IR

Conference Call Participants

Olivia Brayer - Cantor Fitzgerald

Farzin Haque - Jefferies

Stacy Ku - TD Cowen

Justin Kim - Oppenheimer

Ed Arce - H.C. Wainwright

David Martin - Bloom Burton

Will Soghikian - SVB Securities

Sahil Dhingra - RBC Capital Markets

Operator

Greetings, and welcome to Aurinia Pharmaceuticals Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Jamie Harrell, Investor Relations for Aurinia Pharmaceuticals. Thank you. You may begin.

Jamie Harrell

Thank you, operator, and thanks everyone for joining today's call and webcast to review and discuss Aurinia's first quarter 2023 financial results and operational highlights. Joining me on the call this morning are Peter Greenleaf, Chief Executive Officer; and Joe Miller, our Chief Financial Officer.

This morning, Aurinia issued a press release announcing its financial results and operational highlights for the first quarter 2023. In addition, the company filed its quarterly financial statements on Form 10-Q. For more information, please refer to Aurinia's filings with the U.S. Securities and Exchange Commission, which are also available on Aurinia's Web site at auriniapharma.com.

During this call, Aurinia may make forward-looking statements based on current expectations. These forward-looking statements are subject to a number of significant risks and uncertainties, and actual results may differ materially. For discussions of factors that could affect Aurinia's future financial results and businesses, please refer to the disclosures in Aurinia's press release and its quarterly statements on the Form 10-Q and annual report on Form 10-K, along with the recent filings with the U.S. Securities and Exchange Commission and Canadian securities authorities. Please note that all statements made during today's call are current as of today, May 4, 2023, unless otherwise noted and are based upon information currently available to us at this time. Except as required by law, Aurinia assumes no obligation to update any such statements.

Now, let me turn the call over to Aurinia's President and CEO, Peter Greenleaf. Peter?

Peter Greenleaf

Thanks, Jamie, and good morning, everyone. I want to thank you all for joining us on today's call. It's been a solid start to 2023, and we're excited to share our company progress through the first three months of the year with you this morning. Today, we'll primarily focus on the company's first quarter, LUPKYNIS' commercial execution and our financial results.